There is great interest in understanding how inherited impaired functionality of cancer-relevant pathways shapes tumor phenotypes, as has been previously demonstrated for bMMRD and BRCA1 germline mutations [6, 8, 9]. The gene discussed is BRCA1; the disease is cancer.